Rapid communication Open Access
Like 0


We estimated risks of severe outcomes in 820,404 symptomatic paediatric COVID-19 cases reported by 10 European Union countries between August 2020 and October 2021. Case and hospitalisation rates rose as transmission increased but severe outcomes were rare: 9,611 (1.2%) were hospitalised, 640 (0.08%) required intensive care and 84 (0.01%) died. Despite increased individual risk (adjusted odds ratio hospitalisation: 7.3; 95% confidence interval: 3.3–16.2; intensive care: 8.7; 6.2–12.3) in cases with comorbidities, most (83.7%) hospitalised children had no comorbidity.


Article metrics loading...

Loading full text...

Full text loading...



  1. European Centre for Disease Prevention and Control (ECDC). COVID-19 in children and the role of school settings in transmission - second update. Stockholm: ECDC; 2021. Available from: https://www.ecdc.europa.eu/en/news-events/covid-19-children-and-role-school-settings-transmission-second-update
  2. R Core Team. R: A language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2021. Available from: http://www.R-project.org
  3. European Centre for Disease Prevention and Control (ECDC). Data on the daily number of new reported COVID-19 cases and deaths by EU/EEA country. Stockholm: ECDC; 2021. Available from: https://www.ecdc.europa.eu/en/publications-data/data-daily-new-cases-covid-19-eueea-country
  4. European Centre for Disease Prevention and Control (ECDC). Data on hospital and ICU admission rates and current occupancy for COVID-19. Stockholm: ECDC; 2021. Available from: https://www.ecdc.europa.eu/en/publications-data/download-data-hospital-and-icu-admission-rates-and-current-occupancy-covid-19
  5. European Centre for Disease Prevention and Control (ECDC). COVID-19 vaccine tracker. Stockholm: ECDC. [Accessed: 24 Nov 2021]. Available from: https://vaccinetracker.ecdc.europa.eu/public/extensions/COVID-19/vaccine-tracker.html#age-group-tab
  6. European Medicines Agency (EMA). EMA starts evaluating use of COVID-19 vaccine Comirnaty in children aged 5 to 11. Amsterdam: EMA; 2021. Available from: https://www.ema.europa.eu/en/news/ema-starts-evaluating-use-covid-19-vaccine-comirnaty-children-aged-5-11
  7. Paul LA, Daneman N, Schwartz KL, Science M, Brown KA, Whelan M, et al. Association of age and pediatric household transmission of SARS-CoV-2 infection. JAMA Pediatr. 2021;175(11):1151-8.  https://doi.org/10.1001/jamapediatrics.2021.2770  PMID: 34398179 
  8. Shi Q, Wang Z, Liu J, Wang X, Zhou Q, Li Q, et al. Risk factors for poor prognosis in children and adolescents with COVID-19: A systematic review and meta-analysis. EClinicalMedicine. 2021;41:101155.  https://doi.org/10.1016/j.eclinm.2021.101155  PMID: 34693233 
  9. Wallace B, Chang D, Woodworth K, DeSisto CL, Simeone R, Ko JY, et al. Illness severity indicators in newborns by COVID-19 status in the United States, March-December 2020. J Perinatol. 2021;2021.  https://doi.org/10.1038/s41372-021-01243-y  PMID: 34728822 
  10. Zimmermann P, Pittet LF, Finn A, Pollard AJ, Curtis N. Should children be vaccinated against COVID-19? Arch Dis Child. 2021:archdischild-2021-323040. PMID: 34732388 
  11. Meuris C, Kremer C, Geerinck A, Locquet M, Bruyère O, Defêche J, et al. Transmission of SARS-CoV-2 after COVID-19 screening and mitigation measures for primary school children attending school in Liège, Belgium. JAMA Netw Open. 2021;4(10):e2128757.  https://doi.org/10.1001/jamanetworkopen.2021.28757  PMID: 34636913 
  12. Dawood FS, Porucznik CA, Veguilla V, Stanford JB, Duque J, Rolfes MA, et al. Incidence rates, household infection risk, and clinical characteristics of SARS-CoV-2 infection among children and adults in Utah and New York City, New York. JAMA Pediatr. 2021;e214217.  https://doi.org/10.1001/jamapediatrics.2021.4217  PMID: 34623377 
  13. European Centre for Disease Prevention and Control (ECDC). TESSy - The European Surveillance System. Coronavirus disease 2019 (COVID-19) data. Reporting Protocol. Version 5. Stockholm: ECDC; 2021. Available from: https://www.ecdc.europa.eu/sites/default/files/documents/COVID-19-NCOV-Reporting-Protocol-v5.pdf

Data & Media loading...

Submit comment
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error